Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/2001
11/01/2001US20010036462 Enhancing immunology response
11/01/2001US20010036459 Cytotoxicity; therapeutic antibody
11/01/2001US20010036457 Anticancer agents
11/01/2001US20010036452 Interleukin-1 muteins useful as vaccine adjuvants
11/01/2001CA2407663A1 Inhibitors of dipeptidyl peptidase iv
11/01/2001CA2407662A1 Inhibitors of dipeptidyl peptidase iv
11/01/2001CA2407504A1 Medicine containing polysaccharide substances for activating apoptosis
11/01/2001CA2407493A1 Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
11/01/2001CA2407449A1 Novel compounds
11/01/2001CA2407445A1 Use of 5-thio-, sulfinyl- and sulfonylpyrazolo¬3,4-b|-pyridines as cyclin dependent kinase inhibitors
11/01/2001CA2407370A1 Heterocycles that are inhibitors of impdh enzyme
11/01/2001CA2407093A1 Substituted phenyl farnesyltransferase inhibitors
11/01/2001CA2407053A1 Pneumovirus ns proteins antagonize the interferon (ifn) response
11/01/2001CA2406949A1 Use of particulate vectors in immunomodulation
11/01/2001CA2406855A1 Novel insulin/igf/relaxin family polypeptides and dnas thereof
11/01/2001CA2406639A1 A thymus expressed human cytochrome p450 (p450tec)
11/01/2001CA2406264A1 Protein phosphatases
11/01/2001CA2405961A1 Bispecific molecules and uses thereof
11/01/2001CA2405103A1 Chemical modification of mammalian urine and blood
10/2001
10/31/2001EP1149903A1 ADAMTS polypeptides, nucleic acids encoding them, and uses thereof
10/31/2001EP1149842A2 Somatostatin antagonists and agonists that act at the sst subtype 2 receptor
10/31/2001EP1149589A1 Proteinaceous adjuvants
10/31/2001EP1149588A1 Proteinaceous adjuvants
10/31/2001EP1149586A1 Bidirectional modulation of immunity
10/31/2001EP1149581A2 Use of rapamycin derivatives in vasculopathies and xenotransplantation
10/31/2001EP1149159A1 Human t cell effectors expressing cd86 molecule and therapeutic use thereof
10/31/2001EP1149116A1 Process for the production of multiple cross-linked hyaluronic acid derivatives
10/31/2001EP1149114A2 Polypeptides involved in immune response
10/31/2001EP1149113A1 Use of agonists or antagonists of mip-3a in therapy
10/31/2001EP1149111A1 Method and composition for angiogenesis inhibition
10/31/2001EP1149091A1 4-(heterocyclylsulfonamido)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists
10/31/2001EP1149074A1 Acetylenic sulfonamide thiol tace inhibitors
10/31/2001EP1148902A1 Method of enhancing needleless transdermal powdered drug delivery
10/31/2001EP1148889A2 Method of treating demyelinating inflammatory disease using ccr1 antagonists
10/31/2001EP1148875A1 Methods and compositions to enhance white blood cell count
10/31/2001EP1148779A2 Expression of secreted human alpha-fetoprotein in transgenic animals
10/31/2001EP1044201A4 3-substituted adenines via2-thioxanthines
10/31/2001EP0723454B1 Novel tripeptides useful in immune and cns therapy
10/31/2001EP0716598B1 Pharmaceutical preparations for the targeted treatment of morbus crohn and colitis ulcerosa
10/31/2001DE10021246A1 New N-substituted benzamide derivatives are tyrosine kinase KDR and FLT inhibitors useful e.g. for treating tumors, psoriasis, rheumatoid arthritis, diabetic retinopathy or liver sclerosis
10/31/2001DE10020505A1 RSV NS Proteine antagonisieren die Interferon (IFN) Antwort RSV NS proteins antagonize the interferon (IFN) response
10/31/2001DE10019252A1 Polydesoxyribonukleotide zur Hemmung der ICAM-1-Genexpression Polydeoxyribonucleotides to inhibit the ICAM-1 gene expression
10/31/2001CN1320126A Oxazolo, thiazolo and selenazolo [4,5-C]-quinolin-4-amines and analoges thereof
10/31/2001CN1320117A 2-substituted heterocyclic sulfonamides
10/31/2001CN1320116A Heterocyclic 2-substituted ketoamides useful for treating hair loss in mammals
10/31/2001CN1320043A Mutant cholera holotoxin as an adjuvant
10/31/2001CN1320042A Seletive treatment of endothelial somatostatin receptors
10/31/2001CN1319403A Medicine for treating allergic purpura
10/31/2001CN1319400A Epiderm specificity transfer factor
10/30/2001US6310226 Vitamin D analogues
10/30/2001US6310181 Adaptor protein FRS2 and related products and methods
10/30/2001US6310177 Compounds and methods for modulating tissue permeability
10/30/2001US6310092 Treating systemic lupus, multiple sclerosis, rheumatoid arthritis, septic shock, erythema nodosum leprosy, septicemia, uveitis, adult respiratory distress syndrome or inflammatory bowel disease
10/30/2001US6310090 Process and product for enhancing immune response in companion animals using a combination of antioxidants
10/30/2001US6310088 Treating condition associated with matrix metalloproteinases or mediated by tumor necrosis factor-alpha or enzymes involved in shedding l-selectin, cd23, tumor necrosis factor receptors, interleukin-6 receptors or interleukin-1 receptors
10/30/2001US6310065 Pyridazinone hydrochloride compound and method for producing the same
10/30/2001US6310063 Aminoalkyl substituted pyrrolo [3,2-E]pyridine and pyrollo [2,3-b]pyrimidine derivatives: modulators of CRF1 receptors
10/30/2001US6309671 Stable glassy state powder formulations
10/30/2001US6309663 Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
10/30/2001US6309646 Derivatizing a polysaccharide with thiols, amines, or hydrazides; reacting the derivatized polysaccharide with a vinylsulfone group; reacting the product with a protein, a peptide, or a hapten
10/30/2001US6309645 A method of suppressing an immune response in a mammal.
10/30/2001CA2090700C Modified antibodies with controlled clearance time
10/30/2001CA2002833C Interferon-gamma binding proteins
10/28/2001CA2345569A1 Somatostatin antagonists and agonists that act at the sst subtype 2 receptor
10/27/2001CA2345444A1 Novel therapeutic processes and useful compositions therefor
10/25/2001WO2001083485A1 Imidazopyrimidine derivatives and triazolopyrimidine derivatives
10/25/2001WO2001079843A2 Screening method for compounds
10/25/2001WO2001079520A1 Hybrid glycosylated products and their production and use
10/25/2001WO2001079510A1 Materials and methods relating to immune responses to fusion proteins
10/25/2001WO2001079487A2 Polydesoxyribonucleotides for inhibiting the expression of the icam-1-gene
10/25/2001WO2001079480A1 Albumin fusion proteins
10/25/2001WO2001079478A1 Factors participating in degranulation of mast cells, dnas encoding the same, method of screening inhibitors of these factors and the inhibitors
10/25/2001WO2001079469A2 Cloning of corynebacteriaceae histidine ammonia lyase and therapeutic uses
10/25/2001WO2001079468A2 Drug metabolizing enzymes
10/25/2001WO2001079445A2 Pluripotent cells comprising allogenic nucleus and mitochondria
10/25/2001WO2001079444A2 Albumin fusion proteins
10/25/2001WO2001079443A2 Albumin fusion proteins
10/25/2001WO2001079442A2 Albumin fusion proteins
10/25/2001WO2001079300A1 Surface-bound antigen binding portions of antibodies that bind to ctla-4 and cd28 and uses therefor
10/25/2001WO2001079299A1 Enhancement of antibody-mediated immune responses
10/25/2001WO2001079291A2 Secreted proteins
10/25/2001WO2001079288A2 Cytokine uses; compositions; methods
10/25/2001WO2001079282A2 Molecules associated with human reproduction
10/25/2001WO2001079281A1 Sheep lice, bovicola ovis, allergen treatment
10/25/2001WO2001079271A1 Albumin fusion proteins
10/25/2001WO2001079259A1 Javelinization of protein antigens to heat shock proteins
10/25/2001WO2001079258A1 Albumin fusion proteins
10/25/2001WO2001079209A2 Diazafluorenone il-8 antagonists
10/25/2001WO2001079188A1 Antihistaminic compounds
10/25/2001WO2001079173A2 Enamine derivatives as cell adhesion molecules
10/25/2001WO2001079164A2 N-substituted dithiocarbamates for the treatment of biological disorders
10/25/2001WO2001079156A1 Halogenated 2-amino-4, 5 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
10/25/2001WO2001078779A2 Antibody alpha4beta7 integrin and its use to treat inflammatory bowel disease
10/25/2001WO2001078777A2 Immunostimulant compositions comprising an aminoalkyl glucosaminide phosphate and qs-21
10/25/2001WO2001078774A2 Recombinant intracellular pathogen vaccines and methods for use
10/25/2001WO2001078772A1 Heat shock protein-based antiviral vaccines
10/25/2001WO2001078769A2 Regulation of systemic immune responses utilizing soluble cd40
10/25/2001WO2001078768A2 Targeted vaccine delivery systems
10/25/2001WO2001078767A2 Pharmaceutical preparations comprising modified peptides
10/25/2001WO2001078766A1 Vaccine against cancerous diseases which is based on mimotopes of antigens expressed on tumor cells
1 ... 852 853 854 855 856 857 858 859 860 861 862 863 864 865 866 867 868 869 870 871 872 ... 1172